ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 109 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2021. The put-call ratio across all filers is 3.95 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,202,629 | +22.7% | 199,441 | +203.0% | 0.01% | +33.3% |
| Q4 2023 | $979,970 | +540.1% | 65,814 | +94.3% | 0.01% | +500.0% |
| Q1 2023 | $153,088 | -62.6% | 33,869 | -6.8% | 0.00% | -50.0% |
| Q4 2022 | $409,563 | -4.3% | 36,341 | -18.8% | 0.00% | 0.0% |
| Q3 2022 | $428,000 | -39.5% | 44,754 | -48.8% | 0.00% | -50.0% |
| Q2 2022 | $707,000 | -17.5% | 87,339 | +72.3% | 0.00% | -42.9% |
| Q1 2022 | $857,000 | -34.1% | 50,694 | -16.2% | 0.01% | -41.7% |
| Q4 2021 | $1,300,000 | – | 60,495 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |